Forge Biologics

company

About

Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.

Details

Last Funding Type
Series C
Last Funding Money Raised
$90M
Industries
Biotechnology,Medical,Therapeutics
Founded date
Jan 1, 2020
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Forge Biologics Holdings, LLC

Forge Biologics is a gene therapy development engine, focused on enabling access to life-changing gene therapies and helping bring them from an idea into reality. The company partners with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups.

It was founded in 2020 and headquartered in Grove City, Ohio.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$330M
Forge Biologics has raised a total of $330M in funding over 2 rounds. Their latest funding was raised on Sep 12, 2022 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 12, 2022 Series C $90M 2 Aisling Capital
Drive Capital
Detail
Jan 10, 2022 Debt Financing $80M 1 MidCap Financial Detail
Jan 10, 2022 Grant 1 State of Ohio Detail
Apr 29, 2021 Series B $120M 6 RA Capital Management Detail
Jul 21, 2020 Series A $40M 2 Perceptive Advisors Detail

Investors

Number of Lead Investors
Number of Investors
6
9
Forge Biologics is funded by 9 investors. Aisling Capital and Drive Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Aisling Capital Yes Series C
Drive Capital Yes Series C
MidCap Financial Yes Debt Financing
State of Ohio Yes Grant
RA Capital Management Yes Series B
Marshall Wace Series B
Octagon Capital Advisors Series B
Perceptive Advisors Series B
Surveyor Capital Series B

Employee Profiles

Number of Employee Profiles
7
Forge Biologics has 7 current employee profiles, including Board member Chris Garabedian
Board member
Executive
Executive
Board member
Executive